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Background: Despite well-documented risks, injectable supplements containing high doses
of  vitamins are commonly used.
Objectives: To describe acute kidney injury (AKI) as a complication of vitamin intoxication.
Methods: Our series consisted of 16 patients with kidney complications resulting from the
use  of veterinary intramuscular injection supplements of vitamin A, D and E. The patients
were  admitted to two referral hospitals in Fortaleza (Brazil) between January 2010 and Jan-
uary  2015.
Results: Patients’ mean age was 28.3 ± 8.9 years (19–53 years), and 11 (68.7%) were male.
Main signs and symptoms upon admission were nausea (68.7%), vomiting (62.5%), weight
loss  (43.7%), epigastric pain (31.2%) and headache (31.2%). At hospital admission the mean
laboratory values were: hemoglobin 10 ± 2.0 g/dL (6.1–14.2), leukocytes 10,542 ± 4871/mm3
(4100–15,100), creatinine 3.9 ± 5.2 mg/dL (0.7–22) and urea 91 ± 88 mg/dL (22–306), respec-
tively. Serum calcium was 12 ± 2.2 mg/dL (8.8–15.5), 24-h urine calcium was 575 ± 329 mg
(10.7–1058), serum PTH was 55 ± 141 pg/mL (2–406), and serum vitamin D concentration was
135  ± 75 ng/mL (22–265). Using KDIGO criteria, AKI was diagnosed in 13 patients (81.2%),
classiﬁed as stage 1 (n = 3), stage 2 (n = 3) or stage 3 (n = 7). No deaths occurred in the study
period.
Conclusions: Excessive use of veterinary vitamin supplements containing high doses of vita-
min A, D and E was associated with AKI. Hypercalcaemia, which was a common ﬁnding,
appears to be a contributing factor to the development of this type of AKI.Please cite this article in press as: De Francesco Daher E, et al. Acute kidney injury due to excessive and prolonged intramuscular injection of
veterinary supplements containing vitamins A, D and E: A series of 16 cases. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.05.017
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Dan˜o  renal  agudo  debido  a  inyección  intramuscular  excesiva
y  prolongada  de  suplementos  veterinarios  con  vitaminas  A,  D  y  E:
serie  de  16  casos
Palabras clave:
Dan˜o renal agudo
Suplementos vitamínicos
Hipercalcemia
r  e  s  u  m  e  n
Antecedentes: Suplementos inyectables que contienen altas dosis de vitaminas son utilizados
con frecuencia, a pesar de los riesgos bien documentados.
Objetivo: Describir la ocurrencia de dan˜o renal agudo (IRA) como complicación de intoxi-
cación por suplementos vitamínicos.
Métodos: Esta es una serie de 16 pacientes con complicaciones renales resultantes de la
utilización de inyección intramuscular de suplementos veterinarios con vitaminas A, D y
E.  Los pacientes fueron ingresados en 2 hospitales de referencia en Fortaleza (Brasil), entre
enero de 2010 y enero de 2015.
Resultados: La edad media de los pacientes fue de 28,3 ± 8,9 an˜os (19–53 an˜os) y 11 (68,7%) eran
varones. Signos y síntomas principales al ingreso fueron náuseas (68,7%), vómitos (62,5%),
pérdida de peso (43,7%), dolor epigástrico (31,2%) y cefalea (31,2%). Al ingreso en el hospital
los  valores medios de laboratorio fueron: hemoglobina 10 ± 2,0 g/dL (6,1–14,2), leucocitos
10.542 ± 4.871/mm3 (4.100–15.100), creatinina 3,9 ± 5,2 mg/dL (0,7–22) y urea 91 ± 88 mg/dL
(22–306), respectivamente. El nivel de calcio sérico fue de 12 ± 2,2 mg/dL (8,8–15,5), el de
calcio  en orina de 24 h fue de 575 ± 329 mg (10,7–1.058), el de PTH sérico fue de 55 ± 141 pg/mL
(2–406) y el nivel de vitamina D sérica fue de 135 ± 75 ng/mL (22–265). Utilizando criterios
KDIGO, se diagnosticó IRA en 13 pacientes (81,2%); fueron clasiﬁcadas como clase 1 (n = 3),
clase 2 (n = 3) y clase 3 (n = 7). No hubo muertes en el período de estudio.
Conclusiones: El uso excesivo de suplementos vitamínicos veterinarios que contienen altas
dosis  de vitamina A, D y E se asoció con IRA. La hipercalcemia, un hallazgo común, parece
ser  un factor que contribuye al desarrollo de este tipo de IRA.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
Information was collected on demographics, length of hos-
pital stay, clinical manifestations, laboratory ﬁndings, needIntroduction
Body sculpting is an increasingly common practice in modern
society.1 Some enthusiasts resort to substance abuse to boost
results, despite the serious health risks involved. A number
of commercially available substances, from anabolic steroids
(hormones promoting muscle anabolism) to oily compounds
(increasing muscle volume by way of retention, without con-
tributing to anabolism), are known to cause severe damage to
the organism.2
One such substance is the compound “ADE”, a veterinary
product containing liposoluble vitamin A, D and E, indicated
for the treatment of vitamin deﬁciency and infection in cattle
and horses. According to the manufacturers, animals should
not be injected with more  than 5 mL  per 120-day period of
fattening. However, much higher doses are used by human
body sculptors.2 The injection of ADE produces a local gran-
ulomatous reaction and encapsulation. If encapsulation fails,
or if the substance enters the blood stream, embolism may
occur, in some cases followed by death.2 In Brazil, human ADE
use was ﬁrst described in the late 1980s, but may have started
earlier.3
The purpose of the present study was to evaluate the occur-
rence of acute kidney injury (AKI) or chronic kidney disease
(CKD) in a series of patients admitted to two Brazilian referral
hospitals due to complications from excessive and prolonged
intramuscular injection of ADE vitamins.Please cite this article in press as: De Francesco Daher E, et al. Acute kidn
veterinary supplements containing vitamins A, D and E: A series of 16 casby-nc-nd/4.0/).
Patients  and  methods
Study  design
This is a descriptive study based on a case series. We have
evaluated a series of 16 patients with kidney complications
resulting from the use of veterinary intramuscular vitamin
supplements containing high doses of vitamin A, D and E. The
patients were admitted to two referral hospitals in Fortaleza
(Northeastern Brazil) between January 2010 and January 2015.
Patients with a history of renal failure, hypertension, diabetes
mellitus, nephrolithiasis, nephrotoxic drug use, or any comor-
bidity potentially detrimental to renal function, were excluded
from the analysis.
Vitamin  supplements  used
All studied patients have used vitamin supplements con-
taining vitamins A, D and E. In each 100 mL  the following
composition was observed: vitamin A 20,000,000 IU,  vitamin D
35,000,000 IU and vitamin E 6000 IU, which represents a very
high dose, higher than the recommended daily intake for
humans.
Study  parametersey injury due to excessive and prolonged intramuscular injection of
es. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.05.017
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Table 1 – Clinical and laboratory characteristics
of 16 patients with acute kidney injury due to vitamin
supplements abuse.
n %
Age (years) 28.3 ± 8.9 –
Gender
Male 11 (68.7%) 68.7
Female 5 (31.3%) 31.3
Length of hospital stay
(days)
15  ± 13 –
Median time between
ﬁrst use and
admission (months)
28  –
Signs and symptoms at admission
Nausea 11 68.7
Vomiting 10 62.5
Weight loss 7 43.7
Epigastric pain 5 31.2
Headache 5 31.2
Fever 4 25
Paresthesia (limbs) 4 25
Polyuria 3 18.7
Syncope 3 18.7
Anorexia 3 18.7
Low back pain 2 12.5
Edema 2 12.5
Nocturia 2 12.5
Pallor 2 12.5
Gynecomastia 1 6.2
Lymphadenopathy 1 6.2
AKI 13 81.2
Laboratory tests
Hbadm (g/dL) 10 ± 2.0 –
Leukocytesadm
(1×/mm3)
10,542  ± 4871 –
Cradm (mg/dL) 3.9–5.2 mg –
Crmax (mg/dL) 4.3 ± 5.2 –
Crdis (mg/dL) 1.6 ± 1.8 –
Uradm (mg/dL) 91 ± 88 –
Urmax (mg/dL) 102 ± 86 –
Urdis (mg/dL) 45 ± 28 –
Caadm (mg/dL) 12–2.2 –
Camax (mg/dL) 13 ± 2.2 –
24 h-Ca (mg/dL) 575 ± 329 –
PTH (pg/mL) 55 ± 141 –
Vitamin D (ng/mL) 135 ± 75 –
Mean ± SD and %.
Hb, hemoglobina (g/dL); Ur, urea (mg/dL); Cr, creatinine (mg/dL); Ca,n  e f r o l o g i a 2 0 1
or dialysis, treatment and mortality. Clinical information
ncluded all clinical signs and symptoms registered upon
dmission and during hospitalization. The laboratory tests
ncluded complete blood count, serum urea, creatinine,
odium, potassium, calcium, aspartate aminotransferase, ala-
ine aminotransferase, parathyroid hormone (PTH), vitamin D
nd urinalysis. Twenty-four-hour urinary calcium levels were
lso registered.
eﬁnitions
KI and CKD were diagnosed and classiﬁed according to
DIGO criteria.4 Due to lack of information on serum creat-
nine levels prior to admission, all patients were assumed to
ave a baseline glomerular ﬁltration rate of 100 mL/min/m2.
he patients were classiﬁed as the highest KDIGO stage
bserved during hospitalization. Oliguria was deﬁned as a
rine output <0.5 mL/kg/h. Dialysis was indicated for patients
ho  remained oliguric after effective hydration for at least
4 h, for refractory hypervolemia, severe metabolic acido-
is or uremia. High blood pressure was deﬁned as systolic
lood pressure ≥140 mmHg  and/or diastolic blood pressure
90 mmHg.
thical  aspects
he study protocol was reviewed and approved by the
esearch Ethics Committees of the General Hospital of For-
aleza and the Walter Cantídio University Hospital.
esults
atients’ mean age was 28.3 ± 8.9 years (19–53 years), and
1 (68.7%) were male. Mean length of hospital stay was 15 ± 13
ays (1–52 days). Upon admission, all patients reported a
istory of intramuscular injection of vitamin supplements
ontaining vitamins A, D and E for esthetic purposes. Six
atients reported concurrent use of anabolic steroids. All
ere body building practitioners and attended gyms regularly.
he median time between the last injection and hospital-
zation was 10 months (range: 1–48 months). The median
ime between the ﬁrst use and hospitalization was 28 months
range: 4–60 months). Table 1 summarizes patients’ clinical
nd laboratory characteristics.
Main signs and symptoms upon admission were nausea
68.7%), vomiting (62.5%), weight loss (43.7%), epigastric pain
31.2%) and headache (31.2%), fever (25%), paresthesia in the
pper and lower limbs (25%), polyuria (18.7%), syncope (18.7%)
nd anorexia (18.7%). Patients also reported low back pain,
dema, nocturia and pallor (12.5% each), and gynecomastia
nd lymphadenopathy (6.2% each).
At hospital admission the mean laboratory values
ere: hemoglobin 10 ± 2.0 g/dL (range 6.1–14.2), leukocytes
0,542 ± 4871/mm3 (4100–15100), creatinine 3.9 ± 5.2 mg/dL
0.7–22) and urea 91 ± 88 mg/dL (22–306), respectively. SerumPlease cite this article in press as: De Francesco Daher E, et al. Acute kidn
veterinary supplements containing vitamins A, D and E: A series of 16 cas
alcium level was 12 ± 2.2 mg/dL (8.8–15.5), 24-h urine cal-
ium level was 575 ± 329 mg  (10.7–1058), median PTH level
as 55 ± 141 pg/mL (2–406), and serum vitamin D concen-
ration was 135 ± 75 ng/mL (22–265). During hospital staycalcium (mg/dL); 24 h-Ca, 24 h calciuria (mg/dL); adm, at admission;
max, maximum at hospital stay; dis, at hospital discharge.
maximum creatinine ranged from 0.8 to 8.6 mg/dL (mean
4.3 ± 5.2 mg/dL) and serum calcium from 10.2 to 16.8 mg/dL
(mean 13 ± 2.2 mg/dL). Laboratory ﬁndings for each patient are
summarized in Table 2.
Three patients had imaging ﬁndings compatible with
nephrocalcinosis and seven had nephrolithiasis. Using KDIGO
criteria, AKI was diagnosed in 13 cases (81.2%) and classiﬁed asey injury due to excessive and prolonged intramuscular injection of
es. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.05.017
stage 1 (23%), stage 2 (23%) or stage 3 (54%). No deaths occurred
in the study period.
Treatment consisted primarily of controlling calcium lev-
els and complications such as acute pancreatitis due to
Please
 cite
 th
is
 article
 in
 p
ress
 as:
 D
e
 Fran
cesco
 D
ah
er
 E,
 et
 al.
 A
cu
te
 kid
n
ey
 in
ju
ry
 d
u
e
 to
 excessive
 an
d
 p
rolon
ged
 in
tram
u
scu
lar
 in
jection
 of
veterin
ary
 su
p
p
lem
en
ts
 con
tain
in
g
 vitam
in
s
 A
,
 D
 an
d
 E:
 A
 series
 of
 16
 cases.
 N
efrologia.
 2016.
 h
ttp
://d
x.d
oi.org/10.1016/j.n
efro.2016.05.017
A
RTICLE IN PRESS
N
EFR
O
-230;
 
N
o.
 of
 Pages
 7
4
 
n
 e
 f
 r
 o
 l
 o
 g
 i
 a
 2
 0
 1
 6
;x
 x
 x
(x
 x
):xxx–xxx
Table 2 – Laboratory tests during hospital stay of 16 patients with kidney injury due to vitamin supplements abuse.
# Age Gender Ht
adm
Hb
adm
WBC
adm
Platelets
adm
Ur
adm
Ur
max
Ur
dis
Cr
adm
Cr
max
Cr  dis AST/ALT
adm
AST/ALT
max
AST/ALT
dis
Na
adm
K  adm Ca
adm
Ca
max
Ca  dis Vit D 24 h
calciuria
PTH
1 22 F 27.5 9.2 7584 397,709 30 45 33 1.6 1.6 1.1 21/14 – – 140 3.5 11.9 12.4 11.1 >150 – –
2 29 M 30 10.1 8214 463,100 62 73 66 1.6 2.4 1.7 19/35 25/52 20/52 139 4.4 11.7 14.6 10 >150 499.8 3.4
3 34 F 26.5 8.9 12,530 288,800 46 80 78 2.5 2.5 1.4 24/14 47/26 – 146 3.5 15.5 16.8 10.1 – 422.8 7
4 23 M 34.7 11.6 4100 200,000 61 61 48 2.5 2.5 1.4 117/73 117/73 – 139 4 – 12.8 9.1 – – –
5 29 F 33.3 11.5 10,800 313,000 32 32 30 1.4 1.5 1.2 58/75 58/75 – 136 2.9 11.8 12.8 11.7 182.4 484.16 8.41
6 28 M 29.6 9.16 6060 286,000 32 – 29 1.1 – 0.9 – – – 139 3.8 9.5 – 8.8 154.4 – –
7 19 M 34.8 11.8 23,900 594,000 54 35 30 3.5 3.5 0.8 – – – 137 4.2 13.3 13.3 7.9 – 1058 –
8 45 F 34.4 11.5 10,540 250,000 32 57 15 1.5 1.5 0.8 – 15/22 15/22 139 3.8 11 11.3 9.8 >160 428.4 –
9 26 M – – 5500 – 55 77 15 2.7 3.7 0.6 – – – 135 3 10.6 16.8 8 116.7 1039.5 –
10 53 M 27.7 9.44 15,100 320,000 68 68 42 3.2 3.2 1.3 40/32 50/25 35/22 139 4.8 14 14 9.6 160 536.3 5.15
11 24 M 30.6 10.9 8350 60,000 200 200 56 8.6 8.6 1.8 30/22 – – 141 3.4 13.8 14.2 – 53.9 330.2 6.32
12 21 M 43.9 14.2 13,000 247,000 22 28 16 0.7 1 0.7 33/44 33/44 22/30 140 4.6 9.2 10.2 10 – – –
13 25 F 25.3 8.02 7480 457,000 – – – 0.79 0.8 0.8 – – – – –  10.01 10.73 10.73 129.1 – 2
14 25 M 19.8 6.1 12,540 31,200 247 247 56 5.8 5.8 1.3 31/29 39/48 – 148 4.9 15 15 12 – – –
15 24 M 20.4 6.8 12,440 114,600 306 306 124 22 22 8.5 – – – 120 4.6 8.8 9 8.6 22.5 10.73 406
16 27 M 33 10.8 – – 122 122 37 4.1 4.1 1.3 43/45 43/111 36/111 136 5.3 14.9 14.9 9.3 265.25 1012 4.1
Ht, hematocrit (%); Hb, hemoglobina (g/dL); WBC, white blood count (1×/mm3); platelets, 1×/mm3; Ur, urea (mg/dL); Cr, creatinine (mg/dL); AST, aspartate aminotransferase (IU/L); ALT, alanine
aminotransferase (IU/L); Na, sodium (mEq/L); K, potassium (mEq/L); Ca, calcium (mg/dL); Vit D, vitamin D (ng/mL); PTH, parathyroid hormone (pg/dL); adm, at admission; max, maximum at hospital
stay; dis, at hospital discharge.
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ypercalcemia (18.7%) and local infections (18.7%) resulting
rom intramuscular injections of vitamin supplements with-
ut sterilization. Hypercalcemia was treated with vigorous
ydration, steroids and loop diuretics. Due to severe AKI, two
atients required dialysis. One (#11) received 5 hemodialy-
is sessions during hospitalization. The other (#15) developed
hronic kidney disease and was started on regular hemodial-
sis three times a week. Six previously non-hypertensive
atients presented hypertensive peaks upon admission.
ypertension persisted in four cases who were discharged
ith prescriptions for anti-hypertensive drugs.
iscussion
 considerable number of patients with severe kidney compli-
ations (including chronic kidney failure) from excessive use
f vitamin supplements are described in this study. Kidney
njury due to vitamin abuse is seldom reported in litera-
ure and it seems to be a frequent complication, at least
mong patients taking very high doses of vitamins (veterinary
oses).5 The possible mechanisms involved in the pathophy-
iology of kidney injury associated with hypercalcemia and
njectable vitamins A, D and E supplements is schematized in
ig. 1.
As in other granulomatous conditions, such as tuberculo-
is, sarcoidosis and fungal infections, vitamin D is converted
xtra-renal into its active form by granuloma cells (especiallyPlease cite this article in press as: De Francesco Daher E, et al. Acute kidn
veterinary supplements containing vitamins A, D and E: A series of 16 cas
acrophages). This increases the intestinal absorption of vita-
in  D-dependent calcium and raises serum calcium levels.6
ypercalcemia and high level of 1.25(OH)2D3 concentrations
ave a negative impact on the parathyroid glands, reducing
Immune
Reabsorption H
Granuloma
Response
25(OH)D3
1,2
Chronic
kidney
disease
Glomerul
Nephrogenic
diabetes
insipidus
Nephrocalcinosis
nephrolithiasis
Na
Vo
Urinary Ca2+
1α(OH)ase
ig. 1 – Possible mechanisms involved in the pathophysiology of
njectable vitamins A, D and E supplements. x(x x):xxx–xxx 5
PTH production and serum levels.7 This pattern was observed
in most of our patients and in most patients reported in the
literature.5,8–10
On the other hand, some believe hypervitaminosis is the
result of the absorption of injected vitamin D.  Further studies
are necessary to clarify the mechanisms involved, but the fact
that a similar reaction occurs when other substances (such as
parafﬁn) are injecting into the muscle, along with the observed
late onset of hypercalcemia (months later), point to granu-
loma formation and extra-renal conversion as the most likely
explanation.3 If the absorption of injected vitamin D were the
culprit, the onset of hypercalcemia would be acute.11–13
The effects of hypervitaminosis A and E in humans are
less studied than hipervitaminosis D. It is known that after
consumption of high doses of vitamin A the concentrations
of retinoids and metabolites are elevated in plasma. Toxic-
ity following high consumption of vitamin A can be acute
(intake >660,000 IU) or chronic, when intake lasts for months
or years (a dose >100,000 IU for more  than 6 months is con-
sidered toxic),14,15 and our patients consumed a dose very
higher than the levels considered toxic. The main effects of
hypervitaminosis A are related to bone metabolism. There is
association between high vitamin A intake and osteoporo-
sis and pathological fractures.14 Other signs and symptoms
of vitamin A toxicity includes include dry skin, nausea,
headache, fatigue, irritability, anorexia, liver disease, hair loss
and alopecia, hyperostosis, high cholesterol and increased
cerebrospinal ﬂuid pressure.15 Hypervitaminosis E is rare, but
it is possible to be more  frequent once consumption of thisey injury due to excessive and prolonged intramuscular injection of
es. Nefrologia. 2016. http://dx.doi.org/10.1016/j.nefro.2016.05.017
vitamin is increasing due to its potentially antioxidant and
antiatherogenic effects. Toxic effects of hypervitaminosis E
includes prolongation of prothrombin time and hemorrhage
ipercalcemia
5(OH)2D3
PTH
Reabsorption
Direct renal
Vasoconstriction
Acute
kidney
injury
ar filtration rate
Dehydration
usea
miting
 kidney injury associated with hypercalcemia and
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(due to antagonist effects of vitamin E against vitamin K),
hypertension, angina and stroke.16 Our patients had nau-
sea, vomiting and headache, which could be attributable to
hypervitaminosis A and E, but these symptoms could also be
consequence of AKI-associated uremia.
In the present case series, kidney injury ranged from rel-
atively mild and reversible acute injury to severe disease
progressing to end-stage chronic kidney failure (as observed
in patient #15). Persistent hypercalcemia with serum cal-
cium levels >11 mg/dL may in up to 20% of cases develop
into nephrogenic diabetes insipidus, which usually reverts
with the resolution of the hypercalcemic condition. Though
not yet fully understood, the mechanism of nephrogenic dia-
betes insipidus possibly involves the inhibition of reabsorption
of sodium chloride in the thick ascending limb of the loop
of Henle (in detriment to countercurrent exchange) and of
vasopressin-mediated water permeability in the terminal col-
lecting duct.17
Hypercalcemia has been shown to downregulate aquapor-
ine 2 protein expression in rat kidney medulla, interfering
with the ability to concentrate urine.18 Calcium deposition
in the medulla (a cause of tubulointerstitial injury) appears
to play an important role in this process.19 The activation of
calcium-sensing receptor can affect the urinary-concentrating
mechanism by acting in both the loop of Henle and the col-
lecting tubules.20
Hypercalciuria secondary to hypercalcemia also leads to
the deposition of calcium in the renal parenchyma, eventu-
ally causing nephrocalcinosis and irreversible damage and
predisposing toward the development of chronic nephropa-
thy. When the concentration of calcium phosphate exceeds
solubility, Randall’s plaques are formed in the basement
membranes of the thin limbs of the loop of Henle in the
inner medullary interstitium.21–23 These calcium phosphate
plaques can extend into the surrounding interstitial tis-
sue, producing medullar nephrocalcinosis, or penetrate the
urothelium where they are believed to provide a nidus
for intratubular stone formation, leading to nephrolithiasis,
obstructive uropathy and kidney injury.24
Thus, nephropathy induced by vitamin supplement abuse
can indeed lead to chronic kidney disease. This sheds light on
the ﬁndings and outcome of patient #15 in our series. Unlike
the other patients, #15 had low calcium and vitamin D levels
and high PTH levels. Combined with anemia and the need for
persistent dialysis, these ﬁndings are an indication of termi-
nal chronic kidney injury. In the absence of other offending
factors, it may be inferred that the condition of this 25-year
old patient was speciﬁcally the result of vitamin supplement
abuse.
Most of our patients experienced acute kidney injury,
but did not develop chronic kidney disease (nephrocalci-
nosis or hydronephrosis). The observed kidney injury may
have involved other mechanisms. Thus, serum calcium lev-
els in excess of 12–15 mg/dL can acutely induce a reversible
decrease in glomerular ﬁltration by direct renal vasoconstric-
tion of the arterioles and decreased extracellular ﬂuid volume
due to anorexia, vomiting and inability to concentrate urinePlease cite this article in press as: De Francesco Daher E, et al. Acute kidn
veterinary supplements containing vitamins A, D and E: A series of 16 cas
(nephrogenic diabetes insipidus).25 Vomiting was a common
symptom in our patients, most likely due to hypercalcemia.
In such cases, kidney function is often fully restored by early x x(x x):xxx–xxx
treatment. On the other hand, non-renal function recovery
or partial recovery in patients with chronic hypercalcemia
with tubular degeneration, ﬁbrosis and nephrocalcinosis are
observed.26
High blood pressure observed in these patients is due
mainly to hypercalcemia or kidney injury. Hypercalcemia
affects the vascular smooth muscle directly increasing vas-
cular resistance, and indirectly increasing catecholamines
levels. However, the impact is much stronger on renal vas-
cular resistance than on peripheral vascular resistance.27
There are also reports associating vitamin A intoxication
with hypercalcemia.28,29 Its mechanism is still poor under-
stood and may include up-regulation of osteoclasts by retinol
metabolites.29
In conclusion, excessive use of veterinary vitamin supple-
ments that containing high doses of vitamin A, D and E is
associated with AKI and prolonged use with CKD.  Hypercal-
cemia, a common ﬁnding, appears to be a contributing factor
for this outcome. The importance of this report is to alert the
medical community to the ongoing and dangerous practice of
vitamin and supplement abuse by young individuals.
Study  limitations
As this is a descriptive study, there are some limitations. We
have described a small number of patients, but this is rep-
resentative of a rare complication (AKI-associated to vitamin
supplements abuse), which is still not well described in liter-
ature. Some laboratory tests, such as creatine kinase (CK), to
rule out rhabdomyolysis, and serum vitamin D were not avail-
able for all patients due to technical and economic problems. It
was not possible to perform a powerful statistical analysis, so
it was not possible to draw statistically signiﬁcant associations
between possible causal factors for AKI.
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